Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
This clinical trial studies the effectiveness of narrow margins in patients with low-risk basal cell carcinoma undergoing surgery to remove skin lesions on the face. A margin is the area of normal tissue around a tumor taken out during surgery to make sure all of the cancer is removed. This clinical trial studies tissue samples to determine the least amount of tissue that must be removed to give an acceptable cure rate. This may allow less normal tissue to be removed from patients and may be a less expensive surgery.
Full description
PRIMARY OBJECTIVES:
I. To determine the success rate of narrow margin excisions of low-risk facial basal cell carcinoma (BCC).
SECONDARY OBJECTIVES:
I. To determine the narrowest excision margin for low-risk facial BCC that gives an acceptable (95%) cure rate over a 3 year follow-up period.
Enrollment
Sex
Volunteers
Inclusion criteria
Location
Well-defined borders
Primary BCC
Patient is not immunosuppressed
There has not been prior radiotherapy to the site
Nodular subtype
No perineural involvement-(no neurological deficits grossly) -
Exclusion criteria
Location
Poorly defined borders
Recurrent BCC
Patient is immunosuppressed
There has been prior radiotherapy to the site -
Primary purpose
Allocation
Interventional model
Masking
179 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal